Grant: Doctoral Research Award: Canada Graduate Scholarships
McMaster University
$105,000.00
Exercise and senolytics as therapeutic strategies for improving skeletal muscle mass and function in advanced age
FY 2023-24
Summary
With advanced age, there is a loss of muscle mass and function, known as sarcopenia, which can lead to an increased risk of falls, disability, infection, and an overall decline in the quality of life. Exercise is currently the most effective treatment for sarcopenia as it can reduce muscle loss and increase muscle mass and strength. A mechanism of aging is the accumulation of senescent cells, which leads to a reduced ability for tissues to function properly. Senescence is a state that cells can enter that permanently stops cell division while releasing factors that negatively affect nearby cells in the surrounding environment. By eliminating senescent cells, the age-related decline in muscle function may be alleviated. To do so we lean on a new class of drugs that selectively kill senescent cells called senolytics which have been used to improve function in aged tissues. Thus senolytic treatment may be used as a therapeutic strategy to treat skeletal muscle, however, it has yet to be fully investigated.
In this study, we aim to determine if exercise and senolytics can be used as an effective treatment to improve muscle function in aging alone or in combination. We will compare biweekly senolytic treatment, 2x/week exercise training program, biweekly senolytic and exercise training program and no treatment in one year old mice for one year. By better understanding the effects senolytics and exercise have on aging, we can develop new strategies to improve muscle function, thus improving the quality of life in the aging population.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
496448
Name
Johnson Amanda
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Exercise and senolytics as therapeutic strategies for improving skeletal muscle mass and function in advanced age
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Aging; Exercise; Molecular Biology; Satellite Cells; Senescence; Senolytics; Skeletal Muscle
Abstract
With advanced age, there is a loss of muscle mass and function, known as sarcopenia, which can lead to an increased risk of falls, disability, infection, and an overall decline in the quality of life. Exercise is currently the most effective treatment for sarcopenia as it can reduce muscle loss and increase muscle mass and strength. A mechanism of aging is the accumulation of senescent cells, which leads to a reduced ability for tissues to function properly. Senescence is a state that cells can enter that permanently stops cell division while releasing factors that negatively affect nearby cells in the surrounding environment. By eliminating senescent cells, the age-related decline in muscle function may be alleviated. To do so we lean on a new class of drugs that selectively kill senescent cells called senolytics which have been used to improve function in aged tissues. Thus senolytic treatment may be used as a therapeutic strategy to treat skeletal muscle, however, it has yet to be fully investigated.
In this study, we aim to determine if exercise and senolytics can be used as an effective treatment to improve muscle function in aging alone or in combination. We will compare biweekly senolytic treatment, 2x/week exercise training program, biweekly senolytic and exercise training program and no treatment in one year old mice for one year. By better understanding the effects senolytics and exercise have on aging, we can develop new strategies to improve muscle function, thus improving the quality of life in the aging population.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Johnson, Amanda
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~